Positive results from first-in-human trial of nanoformed piroxicam
Overcoming Drug Development Challenges with Nanotechnology: Piroxicam, a commercially available non-steroidal anti-inflammatory drug, was nanoformed as a model compound to demonstrate the potential benefits of our CESS(R) nanoforming technology for improving solubility, dissolution and in vivo absorption.
Video: Bio-Europe panel discussion
Our Head of AI, Prof. Jukka Corander joined a panel discussion at BIO-Europe Spring 2021 on “Big data & AI: applications in the real world”. Watch the video to find out out how Sparse Data AI & specifically STARMAP® can transform healthcare.
Nanoparticle Engineering: Revolutionising Oral Drug Delivery ‘White Paper’
Our CTO Niklas Sandler, and Pharmaceutical Development Manager Satu Lakio explain how our nanoparticle engineering technology is revolutionizing oral drug delivery by enhancing solubility and bioavailability.
Avanza Börsdag
Our CEO Edward Hæggström, CFO Albert Hæggström, and CCO Christian Jones present an overview of our nanoforming platform technology at Avanza Börsdag.
Recording of conference call in conjunction with press release
A record of the conference call held to discuss Nanoform’s initiation of the first human trial of a drug candidate nanoformed using our proprietary CESS® technology.
PharmTech
Nanoform scientists outline how our innovative CESS® technology can help overcome the obstacles many drug candidates face when trying to make it through clinical trials.
ONdrugDelivery
Our CTO, Niklas Sandler, and Pharmaceutical Development Manager, Satu Lakio, discuss the advantages of our nanoparticle engineering technology in oral drug development and delivery by boosting solubility and bioavailability.
Business Trends
Our CCO, Christian Jones, discusses the launch our US subsidiary and the extension our partnership with Orion Corporation with Business Trends Magazine.
CHEManager
Nanoform CEO Edward Haeggström and CFO Albert Haeggström discussed the benefits of our cutting-edge nanoforming technology for improving efficiency in Pharma and increasing the rate of drug approval for market with CHEManager.
Nanoform Brochure
In this brochure we share our story, explaining how our unique nanoforming services, including our game-changing CESS® technology, can provide solutions to drug development challenges in Pharma.
Chemicals Knowledge Hub
Our CBO, Dr. Gonçalo Rebelo de Andrade, discusses with Chemicals Knowledge Hub magazine how our nanoforming technology can improve efficiency in the pharmaceutical industry by creating new avenues for drug delivery.
The Small Molecule Manufacturer
Our CCO, Christian Jones, shared his insights with The Medicine Maker into how our nanoforming technology can improve efficiency and create new opportunities for drug development.
Chemistry World
Our CTO, Niklas Sandler, examines the importance of technological innovation for treating age-related diseases in Chemistry World’s Future of Pharma digital supplement.
Chemistry World
Our scientists discuss the advantages of applying a multidisciplinary approach to Pharma innovation in the Chemistry World - Voices in Chemistry digital supplement.
Cleanroom Technology
Our CTO, Niklas Sandler, discusses the growing demand for nanoformed drug particles and the advantages of our proprietary nanoforming technology offers with Cleanroom Technology Magazine.
Technology Networks
Our Head of AI, Jukka Corrander, spoke to Technology Networks about our innovative use of sparse data AI with our proprietary STARMAP™ technology.
BioPharm International
Our CBO, Gonçalo Rebelo de Andrade, discusses the advantages offered by our excipient-free nanoforming technology with BioPharm International.
European Pharmaceutical Manufacturer
Our CTO, Niklas Sandler, explains how our innovative use of nanoforming technology and sparse-data AI is being used to enhance drug molecules in the European Pharmaceutical Manufacturer.